Table of Content

1 Brucellosis Vaccines Market Overview
1.1 Brucellosis Vaccines Product Overview
1.2 Brucellosis Vaccines Market Segment by Type
1.2.1 S19 Vaccine
1.2.2 RB51 Vaccine Strain
1.3 Global Brucellosis Vaccines Market Size by Type
1.3.1 Global Brucellosis Vaccines Market Size Overview by Type (2018-2034)
1.3.2 Global Brucellosis Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Brucellosis Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Brucellosis Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Brucellosis Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Brucellosis Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Brucellosis Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Brucellosis Vaccines Sales Breakdown by Type (2018-2024)
2 Global Brucellosis Vaccines Market Competition by Company
2.1 Global Top Players by Brucellosis Vaccines Sales (2018-2024)
2.2 Global Top Players by Brucellosis Vaccines Revenue (2018-2024)
2.3 Global Top Players by Brucellosis Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Brucellosis Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Brucellosis Vaccines Market Competitive Situation and Trends
2.5.1 Brucellosis Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Brucellosis Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Brucellosis Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Brucellosis Vaccines Market
2.8 Key Manufacturers Brucellosis Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Brucellosis Vaccines Status and Outlook by Region
3.1 Global Brucellosis Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Brucellosis Vaccines Historic Market Size by Region
3.2.1 Global Brucellosis Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Brucellosis Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Brucellosis Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Brucellosis Vaccines Forecasted Market Size by Region
3.3.1 Global Brucellosis Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Brucellosis Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Brucellosis Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Brucellosis Vaccines by Application
4.1 Brucellosis Vaccines Market Segment by Application
4.1.1 Cattle
4.1.2 Sheep
4.1.3 Others
4.2 Global Brucellosis Vaccines Market Size by Application
4.2.1 Global Brucellosis Vaccines Market Size Overview by Application (2018-2034)
4.2.2 Global Brucellosis Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Brucellosis Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Brucellosis Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Brucellosis Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Brucellosis Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Brucellosis Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Brucellosis Vaccines Sales Breakdown by Application (2018-2024)
5 North America Brucellosis Vaccines by Country
5.1 North America Brucellosis Vaccines Historic Market Size by Country
5.1.1 North America Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Brucellosis Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Brucellosis Vaccines Sales in Value by Country (2018-2024)
5.2 North America Brucellosis Vaccines Forecasted Market Size by Country
5.2.1 North America Brucellosis Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Brucellosis Vaccines Sales in Value by Country (2024-2034)
6 Europe Brucellosis Vaccines by Country
6.1 Europe Brucellosis Vaccines Historic Market Size by Country
6.1.1 Europe Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Brucellosis Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Brucellosis Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Brucellosis Vaccines Forecasted Market Size by Country
6.2.1 Europe Brucellosis Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Brucellosis Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Brucellosis Vaccines by Region
7.1 Asia-Pacific Brucellosis Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Brucellosis Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Brucellosis Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Brucellosis Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Brucellosis Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Brucellosis Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Brucellosis Vaccines Sales in Value by Region (2024-2034)
8 Latin America Brucellosis Vaccines by Country
8.1 Latin America Brucellosis Vaccines Historic Market Size by Country
8.1.1 Latin America Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Brucellosis Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Brucellosis Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Brucellosis Vaccines Forecasted Market Size by Country
8.2.1 Latin America Brucellosis Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Brucellosis Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Brucellosis Vaccines by Country
9.1 Middle East and Africa Brucellosis Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Brucellosis Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Brucellosis Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Brucellosis Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Brucellosis Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Brucellosis Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Jinyu
10.1.1 Jinyu Company Information
10.1.2 Jinyu Introduction and Business Overview
10.1.3 Jinyu Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Jinyu Brucellosis Vaccines Products Offered
10.1.5 Jinyu Recent Development
10.2 Colorado Serum
10.2.1 Colorado Serum Company Information
10.2.2 Colorado Serum Introduction and Business Overview
10.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Colorado Serum Brucellosis Vaccines Products Offered
10.2.5 Colorado Serum Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Boehringer Ingelheim Brucellosis Vaccines Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Biogenesis-Bago
10.4.1 Biogenesis-Bago Company Information
10.4.2 Biogenesis-Bago Introduction and Business Overview
10.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Biogenesis-Bago Brucellosis Vaccines Products Offered
10.4.5 Biogenesis-Bago Recent Development
10.5 Vetal Company
10.5.1 Vetal Company Company Information
10.5.2 Vetal Company Introduction and Business Overview
10.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Vetal Company Brucellosis Vaccines Products Offered
10.5.5 Vetal Company Recent Development
10.6 CZ Veterinaria
10.6.1 CZ Veterinaria Company Information
10.6.2 CZ Veterinaria Introduction and Business Overview
10.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 CZ Veterinaria Brucellosis Vaccines Products Offered
10.6.5 CZ Veterinaria Recent Development
10.7 SYVA Laboratorios
10.7.1 SYVA Laboratorios Company Information
10.7.2 SYVA Laboratorios Introduction and Business Overview
10.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 SYVA Laboratorios Brucellosis Vaccines Products Offered
10.7.5 SYVA Laboratorios Recent Development
10.8 Indian Immunologicals
10.8.1 Indian Immunologicals Company Information
10.8.2 Indian Immunologicals Introduction and Business Overview
10.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Indian Immunologicals Brucellosis Vaccines Products Offered
10.8.5 Indian Immunologicals Recent Development
10.9 Qilu
10.9.1 Qilu Company Information
10.9.2 Qilu Introduction and Business Overview
10.9.3 Qilu Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Qilu Brucellosis Vaccines Products Offered
10.9.5 Qilu Recent Development
10.10 Tecnovax
10.10.1 Tecnovax Company Information
10.10.2 Tecnovax Introduction and Business Overview
10.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Tecnovax Brucellosis Vaccines Products Offered
10.10.5 Tecnovax Recent Development
10.11 Hester Biosciences
10.11.1 Hester Biosciences Company Information
10.11.2 Hester Biosciences Introduction and Business Overview
10.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Hester Biosciences Brucellosis Vaccines Products Offered
10.11.5 Hester Biosciences Recent Development
10.12 Zoetis
10.12.1 Zoetis Company Information
10.12.2 Zoetis Introduction and Business Overview
10.12.3 Zoetis Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Zoetis Brucellosis Vaccines Products Offered
10.12.5 Zoetis Recent Development
10.13 Onderstepoort Biological
10.13.1 Onderstepoort Biological Company Information
10.13.2 Onderstepoort Biological Introduction and Business Overview
10.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Onderstepoort Biological Brucellosis Vaccines Products Offered
10.13.5 Onderstepoort Biological Recent Development
10.14 Instituto Rosenbusch
10.14.1 Instituto Rosenbusch Company Information
10.14.2 Instituto Rosenbusch Introduction and Business Overview
10.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Instituto Rosenbusch Brucellosis Vaccines Products Offered
10.14.5 Instituto Rosenbusch Recent Development
10.15 Ceva Sante Animale
10.15.1 Ceva Sante Animale Company Information
10.15.2 Ceva Sante Animale Introduction and Business Overview
10.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Ceva Sante Animale Brucellosis Vaccines Products Offered
10.15.5 Ceva Sante Animale Recent Development
10.16 Calier & Biologicos Laverlam
10.16.1 Calier & Biologicos Laverlam Company Information
10.16.2 Calier & Biologicos Laverlam Introduction and Business Overview
10.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Products Offered
10.16.5 Calier & Biologicos Laverlam Recent Development
10.17 Biovet
10.17.1 Biovet Company Information
10.17.2 Biovet Introduction and Business Overview
10.17.3 Biovet Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Biovet Brucellosis Vaccines Products Offered
10.17.5 Biovet Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Brucellosis Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Brucellosis Vaccines Industrial Chain Analysis
11.4 Brucellosis Vaccines Market Dynamics
11.4.1 Brucellosis Vaccines Industry Trends
11.4.2 Brucellosis Vaccines Market Drivers
11.4.3 Brucellosis Vaccines Market Challenges
11.4.4 Brucellosis Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Brucellosis Vaccines Distributors
12.3 Brucellosis Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of S19 Vaccine
Table 2. Major Company of RB51 Vaccine Strain
Table 3. Global Brucellosis Vaccines Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Brucellosis Vaccines Sales by Type (2018-2024) & (M Doses)
Table 5. Global Brucellosis Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Brucellosis Vaccines Sales by Type (2018-2024) & (US& Million)
Table 7. Global Brucellosis Vaccines Market Share in Value by Type (2018-2024)
Table 8. Global Brucellosis Vaccines Price by Type (2018-2024) & (USD/K Doses)
Table 9. Global Brucellosis Vaccines Sales by Type (2024-2034) & (M Doses)
Table 10. Global Brucellosis Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Brucellosis Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Brucellosis Vaccines Sales Market Share in Value by Type (2024-2034)
Table 13. Global Brucellosis Vaccines Price by Type (2024-2034) & (USD/K Doses)
Table 14. North America Brucellosis Vaccines Sales by Type (2018-2024) & (M Doses)
Table 15. North America Brucellosis Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Brucellosis Vaccines Sales (M Doses) by Type (2018-2024)
Table 17. Europe Brucellosis Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Brucellosis Vaccines Sales (M Doses) by Type (2018-2024)
Table 19. Asia-Pacific Brucellosis Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Brucellosis Vaccines Sales (M Doses) by Type (2018-2024)
Table 21. Latin America Brucellosis Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Brucellosis Vaccines Sales (M Doses) by Type (2018-2024)
Table 23. Middle East and Africa Brucellosis Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Brucellosis Vaccines Sales by Company (2018-2024) & (M Doses)
Table 25. Global Brucellosis Vaccines Sales Share by Company (2018-2024)
Table 26. Global Brucellosis Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Brucellosis Vaccines Revenue Share by Company (2018-2024)
Table 28. Global Market Brucellosis Vaccines Price by Company (2018-2024) & (USD/K Doses)
Table 29. Global Brucellosis Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Brucellosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Brucellosis Vaccines as of 2022)
Table 32. Date of Key Manufacturers Enter into Brucellosis Vaccines Market
Table 33. Key Manufacturers Brucellosis Vaccines Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Brucellosis Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Brucellosis Vaccines Sales by Region (2018-2024) & (M Doses)
Table 37. Global Brucellosis Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Brucellosis Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Brucellosis Vaccines Sales Market Share in Value by Region (2018-2024)
Table 40. Global Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 41. Global Brucellosis Vaccines Sales by Region (2024-2034) & (M Doses)
Table 42. Global Brucellosis Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Brucellosis Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Brucellosis Vaccines Sales Market Share in Value by Region (2024-2034)
Table 45. Global Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2024-2034)
Table 46. Global Brucellosis Vaccines Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Brucellosis Vaccines Sales by Application (2018-2024) & (M Doses)
Table 48. Global Brucellosis Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Brucellosis Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Brucellosis Vaccines Sales Market Share in Value by Application (2018-2024)
Table 51. Global Brucellosis Vaccines Price by Application (2018-2024) & (USD/K Doses)
Table 52. Global Brucellosis Vaccines Sales by Application (2024-2034) & (M Doses)
Table 53. Global Brucellosis Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Brucellosis Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Brucellosis Vaccines Sales Market Share in Value by Application (2024-2034)
Table 56. Global Brucellosis Vaccines Price by Application (2024-2034) & (USD/K Doses)
Table 57. North America Brucellosis Vaccines Sales by Application (2018-2024) (M Doses)
Table 58. North America Brucellosis Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Brucellosis Vaccines Sales by Application (2018-2024) (M Doses)
Table 60. Europe Brucellosis Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Brucellosis Vaccines Sales by Application (2018-2024) (M Doses)
Table 62. Asia-Pacific Brucellosis Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Brucellosis Vaccines Sales by Application (2018-2024) (M Doses)
Table 64. Latin America Brucellosis Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Brucellosis Vaccines Sales by Application (2018-2024) (M Doses)
Table 66. Middle East and Africa Brucellosis Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Brucellosis Vaccines Sales by Country (2018-2024) & (M Doses)
Table 68. North America Brucellosis Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Brucellosis Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Brucellosis Vaccines Sales Market Share in Value by Country (2018-2024)
Table 71. North America Brucellosis Vaccines Sales by Country (2024-2034) & (M Doses)
Table 72. North America Brucellosis Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Brucellosis Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Brucellosis Vaccines Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Brucellosis Vaccines Sales by Country (2018-2024) & (M Doses)
Table 76. Europe Brucellosis Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Brucellosis Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Brucellosis Vaccines Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Brucellosis Vaccines Sales by Country (2024-2034) & (M Doses)
Table 80. Europe Brucellosis Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Brucellosis Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Brucellosis Vaccines Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Brucellosis Vaccines Sales by Region (2018-2024) & (M Doses)
Table 84. Asia-Pacific Brucellosis Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Brucellosis Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Brucellosis Vaccines Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Brucellosis Vaccines Sales by Region (2024-2034) & (M Doses)
Table 88. Asia-Pacific Brucellosis Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Brucellosis Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Brucellosis Vaccines Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Brucellosis Vaccines Sales by Country (2018-2024) & (M Doses)
Table 92. Latin America Brucellosis Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Brucellosis Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Brucellosis Vaccines Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Brucellosis Vaccines Sales by Country (2024-2034) & (M Doses)
Table 96. Latin America Brucellosis Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Brucellosis Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Brucellosis Vaccines Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Brucellosis Vaccines Sales by Country (2018-2024) & (M Doses)
Table 100. Middle East and Africa Brucellosis Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Brucellosis Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Brucellosis Vaccines Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Brucellosis Vaccines Sales by Country (2024-2034) & (M Doses)
Table 104. Middle East and Africa Brucellosis Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Brucellosis Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Brucellosis Vaccines Sales Market Share in Value by Country (2024-2034)
Table 107. Jinyu Company Information
Table 108. Jinyu Introduction and Business Overview
Table 109. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 110. Jinyu Brucellosis Vaccines Product
Table 111. Jinyu Recent Development
Table 112. Colorado Serum Company Information
Table 113. Colorado Serum Introduction and Business Overview
Table 114. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 115. Colorado Serum Brucellosis Vaccines Product
Table 116. Colorado Serum Recent Development
Table 117. Boehringer Ingelheim Company Information
Table 118. Boehringer Ingelheim Introduction and Business Overview
Table 119. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 120. Boehringer Ingelheim Brucellosis Vaccines Product
Table 121. Boehringer Ingelheim Recent Development
Table 122. Biogenesis-Bago Company Information
Table 123. Biogenesis-Bago Introduction and Business Overview
Table 124. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 125. Biogenesis-Bago Brucellosis Vaccines Product
Table 126. Biogenesis-Bago Recent Development
Table 127. Vetal Company Company Information
Table 128. Vetal Company Introduction and Business Overview
Table 129. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 130. Vetal Company Brucellosis Vaccines Product
Table 131. Vetal Company Recent Development
Table 132. CZ Veterinaria Company Information
Table 133. CZ Veterinaria Introduction and Business Overview
Table 134. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 135. CZ Veterinaria Brucellosis Vaccines Product
Table 136. CZ Veterinaria Recent Development
Table 137. SYVA Laboratorios Company Information
Table 138. SYVA Laboratorios Introduction and Business Overview
Table 139. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 140. SYVA Laboratorios Brucellosis Vaccines Product
Table 141. SYVA Laboratorios Recent Development
Table 142. Indian Immunologicals Company Information
Table 143. Indian Immunologicals Introduction and Business Overview
Table 144. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 145. Indian Immunologicals Brucellosis Vaccines Product
Table 146. Indian Immunologicals Recent Development
Table 147. Qilu Company Information
Table 148. Qilu Introduction and Business Overview
Table 149. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 150. Qilu Brucellosis Vaccines Product
Table 151. Qilu Recent Development
Table 152. Tecnovax Company Information
Table 153. Tecnovax Introduction and Business Overview
Table 154. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 155. Tecnovax Brucellosis Vaccines Product
Table 156. Tecnovax Recent Development
Table 157. Hester Biosciences Company Information
Table 158. Hester Biosciences Introduction and Business Overview
Table 159. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 160. Hester Biosciences Brucellosis Vaccines Product
Table 161. Hester Biosciences Recent Development
Table 162. Zoetis Company Information
Table 163. Zoetis Introduction and Business Overview
Table 164. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 165. Zoetis Brucellosis Vaccines Product
Table 166. Zoetis Recent Development
Table 167. Onderstepoort Biological Company Information
Table 168. Onderstepoort Biological Introduction and Business Overview
Table 169. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 170. Onderstepoort Biological Brucellosis Vaccines Product
Table 171. Onderstepoort Biological Recent Development
Table 172. Instituto Rosenbusch Company Information
Table 173. Instituto Rosenbusch Introduction and Business Overview
Table 174. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 175. Instituto Rosenbusch Brucellosis Vaccines Product
Table 176. Instituto Rosenbusch Recent Development
Table 177. Ceva Sante Animale Company Information
Table 178. Ceva Sante Animale Introduction and Business Overview
Table 179. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 180. Ceva Sante Animale Brucellosis Vaccines Product
Table 181. Ceva Sante Animale Recent Development
Table 182. Calier & Biologicos Laverlam Company Information
Table 183. Calier & Biologicos Laverlam Introduction and Business Overview
Table 184. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 185. Calier & Biologicos Laverlam Brucellosis Vaccines Product
Table 186. Calier & Biologicos Laverlam Recent Development
Table 187. Biovet Company Information
Table 188. Biovet Introduction and Business Overview
Table 189. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 190. Biovet Brucellosis Vaccines Product
Table 191. Biovet Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Brucellosis Vaccines Market Trends
Table 195. Brucellosis Vaccines Market Drivers
Table 196. Brucellosis Vaccines Market Challenges
Table 197. Brucellosis Vaccines Market Restraints
Table 198. Brucellosis Vaccines Distributors List
Table 199. Brucellosis Vaccines Downstream Customers
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Brucellosis Vaccines Product Picture
Figure 2. Global Brucellosis Vaccines Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Brucellosis Vaccines Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Brucellosis Vaccines Sales Status and Outlook (2018-2034) & (M Doses)
Figure 5. Product Picture of S19 Vaccine
Figure 6. Global S19 Vaccine Sales YoY Growth (2018-2034) & (M Doses)
Figure 7. Product Picture of RB51 Vaccine Strain
Figure 8. Global RB51 Vaccine Strain Sales YoY Growth (2018-2034) & (M Doses)
Figure 9. Global Brucellosis Vaccines Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Brucellosis Vaccines Sales Market Share by Type in 2022 & 2034
Figure 11. North America Brucellosis Vaccines Sales Market Share in Volume by Type in 2022
Figure 12. North America Brucellosis Vaccines Sales Market Share in Value by Type in 2022
Figure 13. Europe Brucellosis Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. Europe Brucellosis Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Brucellosis Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Brucellosis Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Latin America Brucellosis Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Brucellosis Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Brucellosis Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Brucellosis Vaccines Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Brucellosis Vaccines Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Brucellosis Vaccines Revenue in 2022
Figure 23. Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Cattle
Figure 25. Global Cattle Sales YoY Growth (2018-2034) & (M Doses)
Figure 26. Product Picture of Sheep
Figure 27. Global Sheep Sales YoY Growth (2018-2034) & (M Doses)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2018-2034) & (M Doses)
Figure 30. Global Brucellosis Vaccines Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Brucellosis Vaccines Sales Market Share by Application in 2022 & 2034
Figure 32. North America Brucellosis Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. North America Brucellosis Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Europe Brucellosis Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Europe Brucellosis Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Brucellosis Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Brucellosis Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Latin America Brucellosis Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Brucellosis Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Brucellosis Vaccines Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Brucellosis Vaccines Manufacturing Cost Structure
Figure 43. Brucellosis Vaccines Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed